Does E09.311 require prior authorization?

No, E09.311 does not require prior authorization (medium confidence). Covered without prior authorization by at least one policy, though another does not cover it.

Backwork Sign up free

`E09.311`, Drug or chemical induced diabetes mellitus with unspecified diabetic retinopathy with macular edema

ICD-10-CM

Prior Authorization

No Prior Auth Required

Covered without prior authorization by at least one policy, though another does not cover it (medium confidence)

Documentation Required

Medical records must document the clinical findings supporting the billed foot care service and be available upon request.
Claims based on systemic-condition diagnosis codes with an asterisk must include the date patient was last seen (DPLS) and the NPI of the M.D. or D.O. actively managing the systemic condition in the medical record and/or claim.
Claims asserting presumptive coverage or systemic-condition exceptions must include the systemic-condition diagnosis code (Group 1) and the valid billing modifier (Q7/Q8/Q9) on the claim.

Key Coverage Criteria

Foot care services are covered when the beneficiary has a listed systemic condition that justifies coverage per Medicare Benefit Policy Manual Pub.100-02, Ch.15, Section 290.4D.
For diagnosis codes designated by an asterisk, the patient must be under the active care of an M.D. or D.O., documented as having been seen for the complicating disease within the 6 months prior to service.
Claims asserting presumptive coverage must include a systemic-condition diagnosis from IOM 100-02 Ch.15 Section 290 Group 1 and a valid billing modifier Q7, Q8, or Q9.
Mycotic nail debridement is covered when mycotic nails are present in the context of a systemic disease with class findings and the appropriate Q modifier on the claim.
Mycotic nail debridement is covered without systemic disease if an ambulatory patient has marked limitation of ambulation, pain, or secondary infection from thickened/dystrophic infected toenail plate.
Mycotic nail debridement is covered without systemic disease if a non-ambulatory patient has mycotic nails and suffers pain or secondary infection due to thickening and dystrophy of the infected toenail plate.

20 Active Policies

CGS-J15-L37578, Micro-Invasive Glaucoma Surgery (MIGS)

J15

CGS-J15-L38662, Implantable Continuous Glucose Monitors (I-CGM)

J15

CGS-J15-L33954, Cataract Extraction

J15

CGS-J15-L38992, Electroretinography (ERG)

J15

CGS-J15-L34399, Ophthalmology: Posterior Segment Imaging (Extended Ophthalmoscopy and Fundus Photography)

J15

CGS-J15-L34394, Visual Fields Testing

J15

CGS-J18-L37578, Micro-Invasive Glaucoma Surgery (MIGS)

J18

CGS-J18-L38662, Implantable Continuous Glucose Monitors (I-CGM)

J18

CGS-J18-L34399, Ophthalmology: Posterior Segment Imaging (Extended Ophthalmoscopy and Fundus Photography)

J18

CGS-J18-L34394, Visual Fields Testing

J18

CGS-J18-L33954, Cataract Extraction

J18

CGS-J18-L38992, Electroretinography (ERG)

J18

WPS-J5-L34760, Scanning Computerized Ophthalmic Diagnostic Imaging (SCODI)

A56916, Billing and Coding: Scanning Computerized Ophthalmic Diagnostic Imaging (SCODI)

WPS-J5-L38686, Implantable Continuous Glucose Monitors (I-CGM)

WPS-J5-L35490, Category III Codes

A56232, Billing and Coding: Foot Care

WPS-J5-L37015, Visual Electrophysiology Testing

A57599, Billing and Coding: Visual Electrophysiology Testing

A58213, Billing and Coding: Implantable Continuous Glucose Monitors (I-CGM)

`E09.311`, Drug or chemical induced diabetes mellitus with unspecified diabetic retinopathy with macular edema

Prior Authorization

Documentation Required

Key Coverage Criteria

20 Active Policies

Related Codes

Have a follow-up question?

E09.311, Drug or chemical induced diabetes mellitus with unspecified diabetic retinopathy with macular edema

Prior Authorization

Documentation Required

Key Coverage Criteria

20 Active Policies

Related Codes

Have a follow-up question?

`E09.311`, Drug or chemical induced diabetes mellitus with unspecified diabetic retinopathy with macular edema